You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Buy Disclosure
Kelly Thomas Patrick · SEC Form 4 · Filed Oct 1, 2026
Buy
Calculated transaction value
$559.74K
Kelly Thomas Patrick Chief Financial Officer
XENE
Transaction date
Sep 30, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed 1 day later
XENE daily price context
Close on/before transaction
$37.19
Sep 30, 2026
First close after public filing
$38.93
Oct 1, 2026
30-day return after filing
-3.37%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 15,000 shares @ $37.32
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-410001
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$559.74K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE Current | Buy | Sep 30, 2026 | $559.74K |